Vitreous-Retina-Macula Consultants of New York PC

Specializes in vitreoretinal diagnosis and surgery

Vitreous-Retina-Macula Consultants of New York PC

Specializes in vitreoretinal diagnosis and surgery

Overview

VRMNY provides specialized retinal care in New York, diagnosing and treating retinal diseases such as macular degeneration and diabetic retinopathy, and performing vitreoretinal surgeries including vitrectomy. Patients receive medical management and surgical treatment across its Manhattan and Downtown centers, with care coordinated by a team of retina specialists. The group stands out through its physicians’ international recognition, academic appointments at Lenox Hill Hospital, NYU, and NY Eye and Ear Infirmary, and its status as the largest retina-vitreous center in the NYC area. The goal is to diagnose, treat, and manage retinal diseases to preserve and restore vision for patients across multiple locations.

Work here?Claim your company

About Vitreous-Retina-Macula Consultants of New York PC

Simplify's Rating

Why Vitreous-Retina-Macula Consultants of New York PC is rated

B-

Rated B on Competitive Edge

Rated B on Growth Potential

Rated C on Differentiation

Industries

Healthcare

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

1974

Get referred to Vitreous-Retina-Macula Consultants of New York PC

See people who can refer or advise you

Simplify's Take

What believers are saying

August 2026 recruitment for MAKO and BOULEVARD expands sponsored-study revenue and prestige.
Dr. Marc Mardelli joins September 2026, adding capacity in Scarsdale and New City.
Updated October 2026 site shows active expansion and consistent patient-facing marketing.

What critics are saying

Care quality and referrals depend on a few star physicians, especially Freund and Spaide.
Private-practice reimbursement pressure hits every injection-heavy location immediately, squeezing margins.
If leading doctors defect to Northwell or academic rivals, the brand loses its core asset.

What makes Vitreous-Retina-Macula Consultants of New York PC unique

VRCNY had 19 Castle Connolly Top Doctors and a Center of Excellence designation in 2026.
It runs 10 New York locations, giving unmatched retina access across five counties.
It stays research-relevant through MAKO and BOULEVARD trial recruitment in August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match
Dental Insurance
Flexible Spending Account
Health Insurance
Life Insurance
Parental Leave
Health Savings Account
Vision Insurance

Company News

PR Newswire

Feb 20th, 2024

Richard F. Spaide, Md Of The Vitreous Retina Macula Consultants Of New York Awarded The Arnall Patz Medal By The Macula Society

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist Richard F. Spaide, MD, was awarded the Arnall Patz Medal at The Macula Society 's 47th Annual Meeting on February 9th, 2024.Dr. Spaide was selected as the honoree of the Arnall Patz Medal by the awards committee of The Macula Society. The Macula Society is the preeminent organization for specialists in the field of macula and retinal diseases. The Arnall Patz Medal is awarded to those who have made outstanding contributions to the understanding of retinal vascular diseases in honor of ophthalmologist Arnall Patz, who is known for his landmark work on retinopathy of prematurity.Dr

PR Newswire

Jan 5th, 2024

Vitreous Retina Macula Consultants Of New York'S K. Bailey Freund, Md Serves As Program Director Of The Atlantic Coast Retina Club (Acrc) And Macula Conference

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist K. Bailey Freund, MD will serve as the Program Director of the 48th Annual Atlantic Coast Retina Club (ACRC) & 24th Macula Conference (Macula 2024).The ACRC was originally co-founded by Lawrence Yannuzzi, MD, co-founder of VRMNY, as a one-day Friday conference open to all retinal specialists. Twenty-three years after the first ACRC meeting, Dr. Yannuzzi created a Saturday program and Macula 2000 was born.The Conference will take place from January 4th through the 6th at the New York Academy of Medicine, 1216 5th Avenue in New York City.Expected to attract between 400-500 retina specialists from around the world, the meetings' participants will learn about new therapies, recent clinical trial results, artificial intelligence, and the latest retinal imaging technologies. The goal of the conference is to help clinicians better manage their patients with macular and retinal disorders and achieve better patient outcomes in their practices."Our meeting this year promises to provide new insight into current critical issues which are inherent in retinal diseases and their treatments," said K

PR Newswire

Oct 17th, 2023

Vitreous Retina Macula Consultants Of New York Announces Participation In Wet Amd Study In Collaboration With Regenxbio

Currently Enrolling Patients Suffering from Wet Age-Related Macular DegenerationNEW YORK, Oct. 17, 2023 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that they have been selected to participate in an innovative Wet AMD study in collaboration with Regenxbio. Wet age-related macular degeneration (wet AMD) is a severe visual impairment caused by the development of new leaky blood vessels in the retina, an essential tissue responsible for vision.VRMNY will be the only Manhattan-based site to participate in the study, which will offer an investigational therapy to patients. The therapy is designed to deliver a targeted gene directly to the retina, in order for these cells to produce an anti-VEGF protein. This groundbreaking approach has the potential to reduce, or even eliminate, the frequent need for anti-VEGF injections, which are the current standard of care for wet AMD.Dr. Richard F

Recently Posted Jobs